Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Citi
Teva
Healthtrust
Moodys
Cipla
Federal Trade Commission
McKesson
Chubb

Generated: June 18, 2018

DrugPatentWatch Database Preview

Hikma Intl Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for HIKMA INTL PHARMS, and when can generic versions of HIKMA INTL PHARMS drugs launch?

HIKMA INTL PHARMS has forty-three approved drugs.

There are five US patents protecting HIKMA INTL PHARMS drugs.

Summary for Hikma Intl Pharms
US Patents:5
Tradenames:30
Ingredients:30
NDAs:43

Drugs and US Patents for Hikma Intl Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Intl Pharms ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride TABLET;ORAL 077545-002 Sep 6, 2007 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Intl Pharms GLYCOPYRROLATE glycopyrrolate TABLET;ORAL 040836-002 Mar 5, 2009 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Intl Pharms METHOCARBAMOL methocarbamol TABLET;ORAL 085123-001 Approved Prior to Jan 1, 1982 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Intl Pharms LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076265-001 Jul 8, 2002 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for HIKMA INTL PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 0.6 mg ➤ Subscribe 2016-06-10
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Julphar
Moodys
Daiichi Sankyo
Fish and Richardson
AstraZeneca
Cerilliant
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.